BN Business News
Add your company to Business Communicator →

Business · 16/01/2020

FDA Releases Draft Guidance on Pediatric Study Plans for Oncology Drugs

The FDA has announced the availability of a draft guidance document addressing questions and answers about pediatric study plans for oncology drugs, in response to industry inquiries following the 2017 FDA Reauthorization Act.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights